secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001628280-25-011275
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 5.03, 5.05, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Health receives Nasdaq approval; trading expected to start March 7 under SNWV
--------------------------------------------------------------------------------

- Common stock approved for listing on Nasdaq Global Market; trading begins March 7, 2025.
- Ticker 'SNWV' unchanged from OTCQB; no stockholder action required.
- Board approved amended bylaws including exclusive forum, proxy rules, and director cap increase to 10.
- New Code of Business Conduct and Ethics adopted effective March 4, 2025.
- CEO Morgan Frank cites 'transition and progress' and expects uplisting to drive shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/snwv-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-011275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer